RT Journal Article
SR Electronic
T1 Domestic violence, mental health, and repeat self-harm in Sri Lanka
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.25.21265461
DO 10.1101/2021.10.25.21265461
A1 Bandara, Piumee
A1 Page, Andrew
A1 Rajapakse, Thilini
A1 Knipe, Duleeka
YR 2021
UL http://medrxiv.org/content/early/2021/10/25/2021.10.25.21265461.abstract
AB Background Evidence on the risk factors for repeat self-harm from low- and middle-income countries is scarce and requires urgent attention.Aims We sought to examine psychosocial correlates of repeat self-harm in Kandy, Sri Lanka.Methods Logistic regression models (adjusting for age and sex) were used to examine associations between study factors and repeat self-harm among adult patients (N=292) admitted for self-poisoning.Results Depression (OR 2.8 95% CI 1.7-4.7), prior psychiatric diagnosis (OR 4.8 95% CI 2.2-10.2), past-year exposure to suicidal behaviour (OR 1.9 95% 1.1-3.3), physical/sexual abuse (OR 3.0 95% CI 1.3-6.9), and psychological abuse (OR 2.3 95% CI 1.3-4.2) were strongly associated with repeat self-harm.Conclusions Identification and management of domestic violence and psychiatric morbidity should be part of routine clinical assessments of patients presenting with self-harm.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the UK Medical Research Council (grant number MC_PC_MR/R019622/1) and Wellcome Trust [204813/Z/16/Z]. DK is supported by the Wellcome Trust and Elizabeth Blackwell Institute Bristol.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Review Committee of University of Peradeniya (Faculty of Medicine) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available at the University of Bristol data repository, data.bris. Given the sensitivity of the data, only researchers at verifiable institutions will be able to access data. Any requests will be reviewed by the University of Bristol Access Committee, which includes senior researchers and representatives from the University. Data will only be released once a controlled data access agreement has been signed by a nominated institutional signatory. https://doi.org/10.5523/bris.37pg6mv6x35r12b98aoq4blcgs.